Stockscreener 앱 받기
3.52
2.10%
0.07
전일 마감가:
$3.45
열려 있는:
$3.5
하루 거래량:
583.32K
Relative Volume:
0.24
시가총액:
$379.86M
수익:
-
순이익/손실:
$-258.08M
주가수익비율:
-1.28
EPS:
-2.75
순현금흐름:
$-202.32M
1주 성능:
+7.72%
1개월 성능:
+16.25%
6개월 성능:
+27.17%
1년 성능:
-69.84%
1일 변동 폭
$3.46
$3.545
1주일 범위
$3.19
$3.595
52주 변동 폭
$2.19
$13.35
Rocket Pharmaceuticals Inc Stock (RCKT) Company Profile
명칭
Rocket Pharmaceuticals Inc
전화
646-440-9100
주소
350 FIFTH AVENUE, NEW YORK, NY
RCKT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RCKT
Rocket Pharmaceuticals Inc
|
3.51 | 373.37M | 0 | -258.08M | -202.32M | -2.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.92 | 116.51B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
786.09 | 82.52B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.51 | 52.67B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
848.71 | 52.08B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
176.44 | 37.70B | 447.02M | -1.18B | -906.14M | -6.1812 |
Rocket Pharmaceuticals Inc Stock (RCKT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-18 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2025-08-20 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2025-07-25 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2025-05-30 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2025-05-28 | 다운그레이드 | Goldman | Neutral → Sell |
| 2025-05-28 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2025-05-28 | 다운그레이드 | Jefferies | Buy → Hold |
| 2025-05-28 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2025-05-28 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-05-27 | 다운그레이드 | Needham | Buy → Hold |
| 2025-05-27 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2025-03-12 | 개시 | BMO Capital Markets | Outperform |
| 2024-12-30 | 개시 | Wedbush | Outperform |
| 2024-12-18 | 개시 | Jefferies | Buy |
| 2024-10-16 | 개시 | Scotiabank | Sector Outperform |
| 2024-04-02 | 개시 | Goldman | Neutral |
| 2023-10-24 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-02-01 | 개시 | Morgan Stanley | Overweight |
| 2022-11-08 | 개시 | Canaccord Genuity | Buy |
| 2022-11-01 | 개시 | BTIG Research | Buy |
| 2022-07-08 | 개시 | Raymond James | Outperform |
| 2021-10-20 | 재개 | Cowen | Outperform |
| 2021-03-02 | 개시 | Stifel | Buy |
| 2021-02-18 | 개시 | Needham | Buy |
| 2020-12-16 | 개시 | UBS | Buy |
| 2020-12-08 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2020-07-02 | 개시 | JP Morgan | Overweight |
| 2020-06-25 | 재개 | BofA/Merrill | Buy |
| 2020-06-01 | 재개 | Oppenheimer | Outperform |
| 2019-11-06 | 개시 | Chardan Capital Markets | Buy |
| 2019-09-26 | 개시 | Piper Jaffray | Overweight |
| 2019-04-23 | 개시 | Robert W. Baird | Outperform |
| 2019-03-15 | 개시 | BofA/Merrill | Buy |
| 2019-02-05 | 개시 | Oppenheimer | Outperform |
| 2018-09-13 | 개시 | Ladenburg Thalmann | Buy |
| 2018-07-10 | 개시 | William Blair | Outperform |
모두보기
Rocket Pharmaceuticals Inc 주식(RCKT)의 최신 뉴스
Can Rocket Pharmaceuticals Inc. Equity Warrant stock maintain growth trajectoryResistance Zone Identification & Free Fastest Return On Investment - Bollywood Helpline
Published on: 2025-12-24 06:58:20 - earlytimes.in
How Rocket Pharmaceuticals Inc. Equity Warrant stock performs in weak economyQuarterly Earnings Review & Free Discover Massive Upside Stocks - Bollywood Helpline
Will Rocket Pharmaceuticals Inc. Equity Warrant stock remain a Wall Street favoriteWeekly Profit Analysis & Long Hold Capital Preservation Plans - Улправда
How buybacks impact Rocket Pharmaceuticals Inc. stock valueMarket Rally & Expert Approved Momentum Trade Ideas - Улправда
Will Rocket Pharmaceuticals Inc. Equity Warrant stock outperform Nasdaq indexJuly 2025 Weekly Recap & Daily Entry Point Alerts - Bölüm Sonu Canavarı
Published on: 2025-12-20 17:40:18 - Улправда
Rocket Pharmaceuticals (NASDAQ:RCKT) Raised to Hold at TD Cowen - MarketBeat
Published on: 2025-12-20 11:21:01 - Улправда
Is Rocket Pharmaceuticals Inc. Equity Warrant stock dividend yield sustainableJuly 2025 Snapshot & Real-Time Chart Breakout Alerts - Улправда
Can Rocket Pharmaceuticals Inc. Equity Warrant stock sustain institutional interest2025 Breakouts & Breakdowns & Weekly Top Performers Watchlists - Улправда
Can Rocket Pharmaceuticals Inc. stock hit analyst price targetsMarket Risk Report & Daily Entry Point Alerts - Улправда
What margin trends mean for Rocket Pharmaceuticals Inc. Equity Warrant stockJuly 2025 Pullbacks & Real-Time Volume Spike Alerts - Улправда
Published on: 2025-12-19 17:54:30 - DonanımHaber
Will Rocket Pharmaceuticals Inc. stock rally after Fed decisions2025 Retail Activity & Long-Term Growth Portfolio Plans - DonanımHaber
Will Rocket Pharmaceuticals Inc. Equity Warrant stock maintain dividend yieldJuly 2025 Levels & Safe Swing Trade Setups - DonanımHaber
Stop Loss: Will Rocket Pharmaceuticals Inc. Equity Warrant stock rally after Fed decisionsWeekly Risk Report & Verified Short-Term Trading Plans - DonanımHaber
Rally Mode: What is the fair value of Rocket Pharmaceuticals Inc. stock nowJuly 2025 WrapUp & Low Drawdown Trading Techniques - ulpravda.ru
Why analysts remain bullish on Rocket Pharmaceuticals Inc. stockWeekly Trade Report & High Accuracy Trade Alerts - Улправда
Published on: 2025-12-18 21:01:52 - Улправда
Published on: 2025-12-18 16:59:15 - Улправда
Market Fear: Will Rocket Pharmaceuticals Inc. Equity Warrant stock continue upward momentum2025 Market Overview & Intraday High Probability Alerts - Улправда
Published on: 2025-12-18 16:13:14 - Улправда
Will Rocket Pharmaceuticals Inc. Equity Warrant stock continue upward momentumWeekly Trading Summary & AI Powered Market Entry Strategies - ulpravda.ru
Rocket Pharmaceuticals Leads Our Trio Of Penny Stock Contenders - Yahoo Finance
Rocket Pharmaceuticals (RCKT) Stock Target Reduced Following Q3 2025 Update on Cash Position - Finviz
Rocket Pharmaceuticals, Inc. (RCKT): A Bull Case Theory - MSN
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
Maverick Capital Ltd. Has $20.49 Million Stock Position in Rocket Pharmaceuticals, Inc. $RCKT - MarketBeat
Working capital per share of Rocket Pharmaceuticals, Inc. – SWB:9IP1 - TradingView — Track All Markets
Rocket Pharmaceuticals (NASDAQ:RCKT) Share Price Passes Below Fifty Day Moving AverageHere's Why - MarketBeat
We're Keeping An Eye On Rocket Pharmaceuticals' (NASDAQ:RCKT) Cash Burn Rate - Sahm
What analysts say about Rocket Pharmaceuticals Inc stockConsumer Goods Stocks & Small Entry Cost Investments - earlytimes.in
Rocket Pharmaceuticals, Inc. (RCKT) Gene Therapy Trial Paused Following Patient Death - MSN
Forecast Cut: Can Rocket Pharmaceuticals Inc. Equity Warrant stock maintain growth trajectoryPortfolio Gains Report & Free Real-Time Volume Trigger Notifications - moha.gov.vn
Is Rocket Pharmaceuticals Inc. (9IP1) stock undervalued after correctionJobs Report & High Accuracy Trade Alerts - Newser
What Wall Street predicts for Rocket Pharmaceuticals Inc. Equity Warrant stock price - Newser
Rocket Pharmaceuticals heads to Lisbon for Cardio Genomics Meeting - Traders Union
Is Rocket Pharmaceuticals Inc. (9IP1) stock among top earnings playsWeekly Profit Report & Expert Approved Trade Ideas - Newser
Will Rocket Pharmaceuticals Inc. (9IP1) stock test record highs in 20252025 Big Picture & Growth Oriented Trade Recommendations - Newser
Is Rocket Pharmaceuticals Inc. Equity Warrant stock near bottom after declineWeekly Stock Analysis & Capital Efficiency Focused Ideas - Newser
Is Rocket Pharmaceuticals Inc. stock positioned well for digital economyPortfolio Return Summary & Reliable Volume Spike Alerts - Newser
How Rocket Pharmaceuticals Inc. (9IP1) stock trades pre earnings2025 Volatility Report & Free Expert Verified Stock Movement Alerts - Newser
Is Rocket Pharmaceuticals Inc. (9IP1) stock a buy on weaknessMarket Rally & Daily Stock Trend Watchlist - Newser
Published on: 2025-12-02 03:22:04 - Newser
Published on: 2025-12-02 19:13:04 - BỘ NỘI VỤ
Class Action Alert: Levi & Korsinsky Reminds Rocket (RCKT) Investors of August 11, 2025 Deadline - The National Law Review
Securities Class Action Lawsuit Filed Against Rocket Pharmaceutic - The National Law Review
Rocket Pharmaceuticals Inc (RCKTW) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
Rocket Pharmaceuticals Inc (RCKT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Rocket Pharmaceuticals Inc 주식 (RCKT) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Shah Gaurav | CEO |
Nov 18 '25 |
Sale |
2.98 |
6,276 |
18,721 |
778,296 |
| Militello John | See Remarks |
Nov 18 '25 |
Sale |
2.98 |
1,086 |
3,240 |
65,920 |
| Wilson Martin | General Counsel |
Nov 18 '25 |
Sale |
2.98 |
1,646 |
4,910 |
383,816 |
0.31%
1.24%
자본화:
|
볼륨(24시간):